Literature DB >> 17956798

Hearing aids for the treatment of tinnitus.

L Del Bo1, U Ambrosetti.   

Abstract

Clinical evidence shows that the use of hearing aids in tinnitus patients provides two benefits: it makes the patient less aware of the tinnitus and it improves communication by reducing the annoying sensation that sounds and voices are masked by the tinnitus. Hearing loss reduces stimulation from external sounds resulting in increased awareness of tinnitus and deprivation of input may change the function of structures of the auditory pathways. Tinnitus is often caused by expression of neural plasticity evoked by deprivation of auditory input. With hearing aid amplification, external sounds can provide sufficient activation of the auditory nervous system to reduce the tinnitus perception and it may elicit expression of neural plasticity that can reprogram the auditory nervous system and thereby have a long-term beneficial effect on tinnitus by restoring neural function. To obtain the best results, hearing aids should be fitted to both ears, use an open ear aid with the widest amplification band, and disabled noise reducing controls. In some cases a combination device would be preferable. The conditions required in order to obtain good results include not only the use of devices, but above all, their adaptation to the needs of the single patient, by counseling and customization. Wearing the hearing aid must become second nature to the patient even though it is only one element of the therapy.

Entities:  

Mesh:

Year:  2007        PMID: 17956798     DOI: 10.1016/S0079-6123(07)66032-4

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  28 in total

1.  An active loudness model suggesting tinnitus as increased central noise and hyperacusis as increased nonlinear gain.

Authors:  Fan-Gang Zeng
Journal:  Hear Res       Date:  2012-05-26       Impact factor: 3.208

2.  A multidisciplinary European guideline for tinnitus: diagnostics, assessment, and treatment.

Authors:  R F F Cima; B Mazurek; H Haider; D Kikidis; A Lapira; A Noreña; D J Hoare
Journal:  HNO       Date:  2019-03       Impact factor: 1.284

3.  Unpleasantness of Amplified Environmental Sound Used in Tinnitus Sound Therapy: A Preliminary Study of Clinical Assessment.

Authors:  Yuna Manabe; Keiko Sato; Shinjiro Fukuda; Takenori Miyashita
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

4.  [Hearing aids, implantable hearing aids and cochlear implants in chronic tinnitus therapy].

Authors:  H Olze; T Zahnert; G Hesse
Journal:  HNO       Date:  2010-10       Impact factor: 1.284

5.  Tinnitus in patients with chronic otitis media before and after middle ear surgery.

Authors:  Dong-Kee Kim; Shi-Nae Park; Min Ji Kim; Se Yun Lee; Kyoung-Ho Park; Sang Won Yeo
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-18       Impact factor: 2.503

6.  Using therapeutic sound with progressive audiologic tinnitus management.

Authors:  James A Henry; Tara L Zaugg; Paula J Myers; Martin A Schechter
Journal:  Trends Amplif       Date:  2008-07-29

7.  Is there any predictor for tinnitus outcome in different types of otologic surgery?

Authors:  Mehmet Habesoglu; Tulay Erden Habesoglu; Cem Karatas; Ahmet Tosun; Ali Okan Gursel; Cagatay Oysu
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-11-15       Impact factor: 2.503

8.  Ondansetron in patients with tinnitus: randomized double-blind placebo-controlled study.

Authors:  Shervin Taslimi; Hamed Vahidi; Ali Pourvaziri; Amirhossein Modabbernia; Arezoo Yeke Fallah; Nasrin Yazdani; Negin Taslimi; Mostafa Hosseini; Masoud Motesadi Zarandi
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-09-22       Impact factor: 2.503

9.  Suppression of tinnitus in a patient with unilateral sudden hearing loss: a case report.

Authors:  Alessandra Fioretti; Giorgia Peri; Alberto Eibenstein
Journal:  Case Rep Otolaryngol       Date:  2012-11-25

10.  Long-term tinnitus suppression with linear octave frequency transposition hearing AIDS.

Authors:  Elisabeth Peltier; Cedric Peltier; Stephanie Tahar; Evelyne Alliot-Lugaz; Yves Cazals
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.